IKS Health announced its unaudited standalone and consolidated financial results for Q2 FY26 (July-September). Consolidated total income reached ₹7,847.46 million. The company posted a profit before tax of ₹2,277.08 million. Basic earnings per share stood at ₹10.81. These results were approved at the Board of Directors Meeting on October 30, 2025.
Financial Performance Overview
IKS Health has released its unaudited financial results for the quarter and half year ended September 30, 2025.
Key Financial Highlights
The key consolidated financial figures include:
- Total income for the quarter: ₹7,847.46 million
- Profit before tax for the quarter: ₹2,277.08 million
- Profit for the period: ₹1,807.19 million
- Basic earnings per share: ₹10.81
Segment Reporting
The Group operates in the Care Enablement Platform segment, providing technology-enabled solutions to Healthcare providers.
Subsidiaries and Associates
The consolidated financial results include those of subsidiaries such as Inventurus Knowledge Solutions Inc, IKS Cares Foundation, Aquity Holdings Inc, Aquity Solutions LLC, Aquity Solutions India Private Limited, Aquity Solutions Australia Pty Limited, Aquity Canada ULC, and IKS WWMG MSO LLC. The results also reflect the share of profit/(loss) from associate IKS WWMG MSO LLC.
Source: BSE